Hydroxychloroquine and chloroquine retinal safety concers durign COVID-19 outbreak

Massimo Nicolò, Lorenzo Ferro Desideri, Matteo Bassetti, Carlo Enrico Traverso

Int Ophthalmol. 2020 Sep 18 : 1–7

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499926/

 

Acute chloroquine and hydroxychloroquine toxicity: a review for emergency clinicians

Alessandra Della Porta, Kasha Bornstein, Austin Coye et al

Am J Emerg Med. 2020 Oct; 38(10): 2209–2217

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369162/

 

Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavírus COVID-19

J.A. Gegúndez-Fernández, J. Zarranz-Ventura, G. Garay-Aramburu, ET AL

Sociedades oftalmológicas españolas

Arch Soc Esp Oftalmol. 2020 Jun; 95(6): 300–310

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183292/

 

COVID-19 and ocular implications: an update

Raffaele Nuzzi, Luigi Ludovico Carucci, Flavia Tripoli

J Ophthalmic Inflamm Infect. 2020; 10: 20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471234/

 

The ocular surface, coronaviruses and COVID-19

Mark DP Willcox, Karen Walsh, Jason J Nichols et al

Clin Exp Optom. 2020 May 13 : 10.1111/cxo.13088

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272971/

 

Are eyes the windows to COVID-19? Systemic review and meta-analysis

Rina La Distia Nora, Ikhwanuliman Putera, Dhiya Farah Khalisha et al

BMJ Open Ophthalmol. 2020; 5(1): e000563

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476422/

 

Ocular findings in COVID-19 patients: a review of direct manifestationns and indirect effects on the eye

Federica Bertoli, Daniele Veritti, Carla Danese et al

J Ophthalmol. 2020; 2020: 4827304.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491448/

 

COVID-19: Ophthalmological aspects of the SARS-CoV 2 global pandemic

Jakob Siedlecki, Victor Brantl, Benedikt Schworm et al

Klin Monbl Augenheilkd. 2020 May; 237(5): 675–680

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295305/

 

Retinal findings in patients with COVID-19: Results from the SERPICO-19 study

Alessandro Invernizzi, Alessandro Torre, Salvatore Parrulli et al

EClinicalMedicine. 2020 Oct; 27: 100550.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502280/

 

The ocular manifestations and transmission of COVID-19: Recommendations for prevention

Dominique M. Dockery, Susannah G. Rowe, Marjorie A. Murphy, Magdalena G. Krzystolik

J Emerg Med. 2020 Jul; 59(1): 137–140

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205711/

 

Diabetic retinopathy screening and the COVID-19 pandemic in Brazil

Malerbi, Fernando Korn, Morales, Paulo Henrique Avila and Regatieri, Caio Vinicius Saito

Arq. Bras. Oftalmol., Aug 2020, vol.83, no.4, p.V-VI

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492020000400001&lng=pt&nrm=iso

 

COVID-19 and the eye: how much do we really know? A best evidence review.

Emparan, Juan Pablo Olivares-de et al.

Arq. Bras. Oftalmol., June 2020, vol.83, no.3, p.250-261

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492020000300016&lng=pt&nrm=iso&tlng=en

 

Implications of Covid-19 in ophthalmology

Pereira, André Luiz Netto et al.

Rev. bras.oftalmol., June 2020, vol.79, no.3, p.217-217

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000300217&lng=pt&nrm=iso

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: dezembro 2020